1.Acute Osteomyelitis Shown as a Cold Lesion on Bone Scan.
Suk Mo LEE ; Sang Gyun BAE ; Myung Rae JO
Korean Journal of Nuclear Medicine 2000;34(6):516-520
Acute osteomyelitis is usually shown as a localized area of increased activity (hot uptake) in the infectious focus on bone scintigraphy. In our patient, absence of radioactivity (cold lesion) was noted in the distal metaphyseal and diaphyseal regions of his right femur. Initial x-ray was interpreted as normal except for mild soft tissue swelling in the right thigh. The lesion was confirmed as an acute osteomyelitis with subperiosteal abscess on surgery. Staphylococcus aureus was the etiologic organism. We describe a case of acute osteomyelitis in a one-year-old boy shown as a cold lesion on bone scan.
Abscess
;
Femur
;
Humans
;
Male
;
Osteomyelitis*
;
Radioactivity
;
Radionuclide Imaging
;
Staphylococcus aureus
;
Technetium Tc 99m Medronate
;
Thigh
2.Thymic Carcinoid Tumor: 1 Case report.
Jae Young LEE ; Myung Chun KIM ; Seh Young YOU ; Hwang Rae JO ; Hong Mo KANG ; Moon Ho YANG
The Korean Journal of Thoracic and Cardiovascular Surgery 1998;31(3):319-323
Thymic carcinoid tumor is a rare mediastinal tumor, which was firstly described by Rosai and Higa in 1972. A carcinoid tumor of the thymus has recently been regarded as a distinct tumor from thymoma, and is probably Kultschizky cell origin. The pathologic diagnosis of thymic carcinoid is made from findings from light microscopy, immunohistochemical studies and electron microscopy. About 50% of thymic carcinoids were seen with endocrinopathies. Recurrences and extrathoracic metastasis are characteristics of thymic carcinoids. Surgical removal of the intial and tumor recurred are considered to be the most effective treatment today. However, the role of the adjuvant radiotherapy and the chemotherapy is still uncertain. Herein we report a case of thymic carcinoid tumor, which was confirmed by operation and pathologic study.
Carcinoid Tumor*
;
Diagnosis
;
Drug Therapy
;
Mediastinal Neoplasms
;
Microscopy
;
Microscopy, Electron
;
Neoplasm Metastasis
;
Radiotherapy, Adjuvant
;
Recurrence
;
Thymoma
;
Thymus Gland
;
Thymus Neoplasms
3.Multiple Myeloma of the Male Breast: A Case Report.
Kum Rae KIM ; Mi Soo HWANG ; Jae Ho JO ; Myung Soo HYUN ; Joon Hyuk CHOI
Journal of the Korean Society of Medical Ultrasound 2007;26(2):95-98
Breast involvement of multiple myeloma is very rare, expecially in men. We describe the mammographic and sonographic findings of multiple myeloma involving the male breast.
Breast Neoplasms
;
Breast*
;
Humans
;
Male*
;
Multiple Myeloma*
;
Ultrasonography
4.Regulation of Host Cell Signaling Pathways by Respiratory Syncytial Virus Nonstructural Protein NS1 and NS2.
Han Bo SHIN ; Myung Soo CHOI ; Chae Min YI ; Ji Eun KIM ; Su Ji JO ; Hye In KIM ; Na Rae LEE ; Kyung Soo INN
Journal of Bacteriology and Virology 2014;44(3):283-289
Human Respiratory Syncytial virus (hRSV) is a leading cause of severe lower respiratory tract diseases in the pediatric population.hRSV frequently causes severe morbidity and mortality in high risk groups including infants with congenital heart disease and the immunosuppressed patients. Although hRSV is recognized as a major public health threat and economic burden worldwide, there is no licensed vaccine and effective therapeutic agent. Viral nonstructural (NS) proteins have been known to play multiple functions for efficient viral replication and pathogenesis. Especially, diverse functions of influenza A virus NS1 have been extensively studies. Recent studies demonstrated that NS1 and NS2 of RSV also exert diverse functions to modulate cellular environment and antiviral immune responses. Since NS proteins of RSV are required for efficient replication and pathogenesis, NS mutant viruses have been tested as live-attenuated vaccines. This review will outline the recent progress in understanding the various functions of RSV NS1 and NS2.
Heart Defects, Congenital
;
Humans
;
Infant
;
Influenza A virus
;
Interferons
;
Mortality
;
Public Health
;
Respiratory Syncytial Virus, Human
;
Respiratory Syncytial Viruses*
;
Respiratory Tract Diseases
;
Vaccines
5.Prevalence and Gender-Related Characteristics of Metabolic Syndrome in Korean Community.
Kyung Taek PARK ; Hack Lyoung KIM ; Sang Hyun KIM ; Myung A KIM ; Euijae LEE ; Jonghanne PARK ; Sang Ho JO ; Sung Rae KIM ; Jaetaek KIM ; Chee Jeong KIM ; Moon Kyu LEE ; Hyun Ho SHIN
Journal of Lipid and Atherosclerosis 2014;3(2):89-96
OBJECTIVE: There are still a limited number of studies assessing the prevalence of metabolic syndrome in the community. The aim of this study is to investigate the prevalence and gender-related characteristics of metabolic syndrome in Korean community. METHODS: A total of 417 community subjects (mean age was 60.7+/-13.6 years, 35.3% were men) who attended the routine check-up were analyzed. National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) III clinical guideline was used to define metabolic syndrome. RESULTS: Metabolic syndrome was diagnosed in 38.1% of study subjects. The prevalence of metabolic syndrome was not different between men and women (men 39.0% vs. women 37.5%, p=0.766). The positive association between age and the prevalence of metabolic syndrome was more pronounced in women (chi2=17.52, p for trend<0.001) than men (chi2=2.38, p for trend=0.123). In young age group (<50 years), the prevalence of metabolic syndrome was higher in men than in women (34.7% vs. 11.7%, p=0.042). This gender difference was not observed in older group (> or =50 years). The most prevalent factor of metabolic syndrome was hypertriglyceridemia (49.9%) and hypertension (47.6%) in both genders. Among metabolic syndrome components, central obesity (40.5% vs. 25.2%, p=0.002) and hypertriglyceridemia (54.5% vs. 41.8%, p=0.015) were more prevalent in women than in men, and the prevalence of other components were similar between genders. CONCLUSIONS: In the community, metabolic syndrome was highly prevalent in middle-aged and elderly Korean adult. Age related change in the prevalence of metabolic syndrome was gender specific. Age and gender effects should be considered for the effective control of metabolic syndrome in the community.
Adult
;
Aged
;
Cholesterol
;
Education
;
Female
;
Humans
;
Hypertension
;
Hypertriglyceridemia
;
Male
;
Obesity, Abdominal
;
Prevalence*
6.TNF-alpha upregulates PTEN via NF-kappaB signaling pathways in human leukemic cells.
Young Rae LEE ; Hong Nu YU ; Eun Mi NOH ; Hyun Jo YOUN ; Eun Kyung SONG ; Myung Kwan HAN ; Chang Sik PARK ; Byung Soo KIM ; Young Seok PARK ; Byung Kwon PARK ; Sung Ho LEE ; Jong Suk KIM
Experimental & Molecular Medicine 2007;39(1):121-127
TNF-alpha plays a variety of biological functions such as apoptosis, inflammation and immunity. PTEN also has various cellular function including cell growth, proliferation, migration and differentiation. Thus, possible relationships between the two molecules are suggested. TNF-alpha has been known to downregulate PTEN via NF-kappaB pathway in the human colon cell line, HT-29. However, here we show the opposite finding that TNF-alpha upregulates PTEN via activation of NF-kappaB in human leukemic cells. TNF-alpha increased PTEN expression at HL-60 cells in a time- and dose-dependent manner, but the response was abolished by disruption of NF-kappaB with p65 anisense phosphorothioate oligonucleotide or pyrrolidine dithiocarbamate. We found that TNF-alpha activated the NF-kappaB pathways, evidenced by the translocation of p65 to the nucleus in TNF-alpha-treated cells. We conclude that TNF-alpha induces upregulation of PTEN expression through NF-kappaB activation in human leukemic cells.
Up-Regulation/*drug effects
;
Tumor Necrosis Factor-alpha/*pharmacology
;
Signal Transduction/*drug effects
;
PTEN Phosphohydrolase/genetics/*metabolism
;
NF-kappa B/genetics/*metabolism
;
Leukemia/genetics/*metabolism
;
Humans
;
Gene Expression
;
Cell Line, Tumor
7.Chronic Alcohol Consumption Results in Greater Damage to the Pancreas Than to the Liver in the Rats.
Seong Su LEE ; Oak Kee HONG ; Anes JU ; Myung Jun KIM ; Bong Jo KIM ; Sung Rae KIM ; Won Ho KIM ; Nam Han CHO ; Moo Il KANG ; Sung Koo KANG ; Dai Jin KIM ; Soon Jib YOO
The Korean Journal of Physiology and Pharmacology 2015;19(4):309-318
Alcohol consumption increases the risk of type 2 diabetes. However, its effects on prediabetes or early diabetes have not been studied. We investigated endoplasmic reticulum (ER) stress in the pancreas and liver resulting from chronic alcohol consumption in the prediabetes and early stages of diabetes. We separated Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a type-2 diabetic animal model, into two groups based on diabetic stage: prediabetes and early diabetes were defined as occurrence between the ages of 11 to 16 weeks and 17 to 22 weeks, respectively. The experimental group received an ethanol-containing liquid diet for 6 weeks. An intraperitoneal glucose tolerance test was conducted after 16 and 22 weeks for the prediabetic and early diabetes groups, respectively. There were no significant differences in body weight between the control and ethanol groups. Fasting and 120-min glucose levels were lower and higher, respectively, in the ethanol group than in the control group. In prediabetes rats, alcohol induced significant expression of ER stress markers in the pancreas; however, alcohol did not affect the liver. In early diabetes rats, alcohol significantly increased most ER stress-marker levels in both the pancreas and liver. These results indicate that chronic alcohol consumption increased the risk of diabetes in prediabetic and early diabetic OLETF rats; the pancreas was more susceptible to damage than was the liver in the early diabetic stages, and the adaptive and proapoptotic pathway of ER stress may play key roles in the development and progression of diabetes affected by chronic alcohol ingestion.
Alcohol Drinking*
;
Animals
;
Body Weight
;
Diet
;
Eating
;
Endoplasmic Reticulum
;
Endoplasmic Reticulum Stress
;
Ethanol
;
Fasting
;
Glucose
;
Glucose Tolerance Test
;
Liver*
;
Models, Animal
;
Pancreas*
;
Prediabetic State
;
Rats*
;
Rats, Inbred OLETF
8.Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Ji Eun JUN ; In Kyung JEONG ; Jae Myung YU ; Sung Rae KIM ; In Kye LEE ; Kyung Ah HAN ; Sung Hee CHOI ; Soo Kyung KIM ; Hyeong Kyu PARK ; Ji Oh MOK ; Yong ho LEE ; Hyuk Sang KWON ; So Hun KIM ; Ho Cheol KANG ; Sang Ah LEE ; Chang Beom LEE ; Kyung Mook CHOI ; Sung Ho HER ; Won Yong SHIN ; Mi Seung SHIN ; Hyo Suk AHN ; Seung Ho KANG ; Jin Man CHO ; Sang Ho JO ; Tae Joon CHA ; Seok Yeon KIM ; Kyung Heon WON ; Dong Bin KIM ; Jae Hyuk LEE ; Moon Kyu LEE
Diabetes & Metabolism Journal 2020;44(1):78-90
BACKGROUND:
Cardiovascular risk remains increased despite optimal low density lipoprotein cholesterol (LDL-C) level induced by intensive statin therapy. Therefore, recent guidelines recommend non-high density lipoprotein cholesterol (non-HDL-C) as a secondary target for preventing cardiovascular events. The aim of this study was to assess the efficacy and tolerability of omega-3 fatty acids (OM3-FAs) in combination with atorvastatin compared to atorvastatin alone in patients with mixed dyslipidemia.
METHODS:
This randomized, double-blind, placebo-controlled, parallel-group, and phase III multicenter study included adults with fasting triglyceride (TG) levels ≥200 and <500 mg/dL and LDL-C levels <110 mg/dL. Eligible subjects were randomized to ATOMEGA (OM3-FAs 4,000 mg plus atorvastatin calcium 20 mg) or atorvastatin 20 mg plus placebo groups. The primary efficacy endpoints were the percent changes in TG and non-HDL-C levels from baseline at the end of treatment.
RESULTS:
After 8 weeks of treatment, the percent changes from baseline in TG (−29.8% vs. 3.6%, P<0.001) and non-HDL-C (−10.1% vs. 4.9%, P<0.001) levels were significantly greater in the ATOMEGA group (n=97) than in the atorvastatin group (n=103). Moreover, the proportion of total subjects reaching TG target of <200 mg/dL in the ATOMEGA group was significantly higher than that in the atorvastatin group (62.9% vs. 22.3%, P<0.001). The incidence of adverse events did not differ between the two groups.
CONCLUSION
The addition of OM3-FAs to atorvastatin improved TG and non-HDL-C levels to a significant extent compared to atorvastatin alone in subjects with residual hypertriglyceridemia.